Sjoerd van Gorp has extensive experience in the life sciences sector across roles in operations, translational research, investment banking and venture capital. Before joining Citryll in 2021 he was Senior Investment Manager at BOM Brabant Ventures where he was instrumental in fundraising and strategic support of early-stage life sciences companies. Prior to joining BOM, Sjoerd was an equity analyst at Kempen & Co, where was involved in capital market transactions for European biotech and medtech companies. He holds a PhD from the University Medical Center Utrecht and is a NVP certified private equity professional.